ArticleAcademic radiology2022
Retrospective Review of a Mobile Mammography Screening Program in an Underserved Population within a Large Metropolitan Area.
Article in Academic radiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 16 citations in OpenAlex.
- Optimizing mobile mammography deployment in Oklahoma 2024: a two-step floating catchment area approach.Geospatial health · 2026Article
- Implementing mobile mammography in primary care: a community-based Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) evaluation.Translational behavioral medicine · 2026Article
- Follow-up after an abnormal screening mammogram: Impact of a pandemic on mobile mammography patients.Journal of clinical imaging science · 2026Article
- Bangkok declarations on cancer control in Asia.The Lancet regional health. Western Pacific · 2025Review
- Melanoma Disparities in Hispanic Populations: Socioeconomic Challenges and Cultural Barriers.Journal of skin cancer · 2025Review
- Addressing Disparities Related to Access of Multimodality Breast Imaging Services Before and During the COVID-19 Pandemic.Academic radiology · 2022Review
- Mobile Mammography Services and Underserved Women.Diagnostics (Basel, Switzerland) · 2022Review
- Mobile mammography in New York City: analysis of 32,350 women utilizing a screening mammogram program.NPJ breast cancer · 2022Article
- Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond.Preventive medicine · 2021Article
- Analysis of Technical Repeat Studies in Screening Mammography.Journal of breast imagingArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
Abstract
RATIONALE AND
objectivesMobile mammography units provide preventive health care to patients facing barriers to annual screening. This study reviews the outcomes of a mobile mammography service during a recent 5-year period. MATERIALS AND
methodsThis retrospective study analyzed the examinations by mobile mammography during a 5-year period (9327 examinations). The patients recalled, biopsies performed, and cancers detected were tallied. The race, age, breast cancer size, lymph node involvement, and metastases were recorded. The positive predictive value (PPV) and cancer detection rate metrics were calculated as outlined by the American College of Radiology Breast Imaging Reporting and Data System Atlas.
resultsThe program identified cancer in 14 cases (cancer detection rate = 1.5 per 1000 examinations [95% confidence interval [CI], 0.9-2.5]) with 11 being invasive. The majority of these cancers were small and of low stage. Lymph node status was determined in 11 of the 14 cases (1 as N1mi, 5 as N0, 4 as N1,1 as N2a). Abnormalities led to 1686 examinations recalled (Recall Rate = 17.8%; PPV 1 = 0.8% [95% CI, 0.5%-1.4%]). One hundred and one were recommended for biopsy (PPV 2 = 13.9% [95% CI, 8.4%-21.9%]), and 98 pursued biopsy (PPV 3 = 14.3% [95% CI, 8.7%-22.6%]). Patient age ranged from 41 to 67 years with an average of 50.6 years.
conclusionThe program detected many cancers in an asymptomatic population facing barriers to breast cancer screening. These findings are underscored by the cancers detected at an early stage with a favorable prognosis and support the need for the development of similar programs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.